StockWatch
·
Pharmaceuticals
Quarterly Result9 Feb 2026, 01:41 pm

Krebs Biochemicals & Industries Ltd.: Approval of Unaudited Financial Results for Q3 and Nine Months Ended December 31, 2025

AI Summary

Krebs Biochemicals & Industries Ltd. announced the outcome of its Board Meeting held on December 31, 2025. The Board approved and took on record the unaudited financial results for the 34th quarter and nine months ended December 31, 2025, along with the Limited Review Report by the Auditors. The meeting commenced at 12:00 Noon and concluded at 01:30 p.m. The company's registered office is located at Kothapalli Village, Kasimkota Mandal, Anakapalli, Visakhapatnam, Andhra Pradesh - 531 031.

Key Highlights

  • Approval of unaudited financial results for Q3 and nine months ended December 31, 2025
  • Limited Review Report by the Auditors submitted
  • Meeting of the Board of Directors held on December 31, 2025
  • Registered office located at Kothapalli Village, Kasimkota Mandal, Anakapalli, Visakhapatnam, Andhra Pradesh - 531 031